Hypogonadal men nonresponders to the PDE5 inhibitor tadalafil benefit from normalization of testosterone levels with a 1% hydroalcoholic testosterone gel in the treatment of erectile dysfunction (TADTEST study) (Q84729341)
Jump to navigation
Jump to search
scientific article published on 01 January 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Hypogonadal men nonresponders to the PDE5 inhibitor tadalafil benefit from normalization of testosterone levels with a 1% hydroalcoholic testosterone gel in the treatment of erectile dysfunction (TADTEST study) |
scientific article published on 01 January 2011 |
Statements
Hypogonadal men nonresponders to the PDE5 inhibitor tadalafil benefit from normalization of testosterone levels with a 1% hydroalcoholic testosterone gel in the treatment of erectile dysfunction (TADTEST study) (English)
Francesco Montorsi
Mario Maggi
Jacques Buvat
Hartmut Porst
Antti Kaipia
Marie Helène Colson
Beatrice Cuzin
Ignacio Moncada
Antonio Martin-Morales
Aksam Yassin
Ian Eardley
John Daniel Dean
Ridwan Shabsigh